Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma

Elisabetta Kuhn, Asli Bahadirli-Talbott, Ie Ming Shih

Research output: Contribution to journalArticle

Abstract

Uterine serous carcinoma accounts for only 10% of all uterine epithelial cancers, but is the leading cause of death among them. The pathogenesis of this aggressive neoplasm has been largely elusive until recently, when comprehensive genome-wide analyses of uterine serous carcinoma have been performed. Among amplified cancer-related genes, CCNE1, encoding for cyclin E1, is frequently amplified in uterine serous carcinoma. In the current study we applied fluorescence in situ hybridization (FISH) to determine CCNE1 copy number in uterine serous carcinoma and concurrent endometrial intraepithelial carcinoma, the noninvasive component of uterine serous carcinoma, and the results were correlated with clinicopathological and molecular features. We found that 20 (45%) of 44 uterine serous carcinomas and 11 (41%) of 27 endometrial intraepithelial carcinomas showed CCNE1 amplification. Overall, we found high concordance in CCNE1 copy number in concurrent uterine serous carcinoma and endometrial intraepithelial carcinoma pairs (P-value=0.0003). No correlation was observed between CCNE1 copy number and clinicopathological features, as well as common mutations previously reported in uterine serous carcinoma. In summary, we confirm that amplification of CCNE1 is a frequent molecular genetic change in uterine serous carcinoma. Moreover, the identification of CCNE1 amplification in many endometrial intraepithelial carcinomas suggests that this genetic event occurs early during tumor progression.

Original languageEnglish (US)
Pages (from-to)1014-1019
Number of pages6
JournalModern Pathology
Volume27
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Carcinoma in Situ
Endometrial Neoplasms
Carcinoma
Uterine Neoplasms
Cyclins
Neoplasm Genes
Fluorescence In Situ Hybridization
Molecular Biology
Cause of Death
Neoplasms
Genome
Mutation

Keywords

  • amplification
  • CCNE1
  • cyclin E1
  • endometrial intraepithelial carcinoma
  • FISH
  • fluorescence in situ hybridization
  • serous carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma. / Kuhn, Elisabetta; Bahadirli-Talbott, Asli; Shih, Ie Ming.

In: Modern Pathology, Vol. 27, No. 7, 2014, p. 1014-1019.

Research output: Contribution to journalArticle

Kuhn, Elisabetta ; Bahadirli-Talbott, Asli ; Shih, Ie Ming. / Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma. In: Modern Pathology. 2014 ; Vol. 27, No. 7. pp. 1014-1019.
@article{1479eff890094321bd7d26055eebebb2,
title = "Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma",
abstract = "Uterine serous carcinoma accounts for only 10{\%} of all uterine epithelial cancers, but is the leading cause of death among them. The pathogenesis of this aggressive neoplasm has been largely elusive until recently, when comprehensive genome-wide analyses of uterine serous carcinoma have been performed. Among amplified cancer-related genes, CCNE1, encoding for cyclin E1, is frequently amplified in uterine serous carcinoma. In the current study we applied fluorescence in situ hybridization (FISH) to determine CCNE1 copy number in uterine serous carcinoma and concurrent endometrial intraepithelial carcinoma, the noninvasive component of uterine serous carcinoma, and the results were correlated with clinicopathological and molecular features. We found that 20 (45{\%}) of 44 uterine serous carcinomas and 11 (41{\%}) of 27 endometrial intraepithelial carcinomas showed CCNE1 amplification. Overall, we found high concordance in CCNE1 copy number in concurrent uterine serous carcinoma and endometrial intraepithelial carcinoma pairs (P-value=0.0003). No correlation was observed between CCNE1 copy number and clinicopathological features, as well as common mutations previously reported in uterine serous carcinoma. In summary, we confirm that amplification of CCNE1 is a frequent molecular genetic change in uterine serous carcinoma. Moreover, the identification of CCNE1 amplification in many endometrial intraepithelial carcinomas suggests that this genetic event occurs early during tumor progression.",
keywords = "amplification, CCNE1, cyclin E1, endometrial intraepithelial carcinoma, FISH, fluorescence in situ hybridization, serous carcinoma",
author = "Elisabetta Kuhn and Asli Bahadirli-Talbott and Shih, {Ie Ming}",
year = "2014",
doi = "10.1038/modpathol.2013.209",
language = "English (US)",
volume = "27",
pages = "1014--1019",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma

AU - Kuhn, Elisabetta

AU - Bahadirli-Talbott, Asli

AU - Shih, Ie Ming

PY - 2014

Y1 - 2014

N2 - Uterine serous carcinoma accounts for only 10% of all uterine epithelial cancers, but is the leading cause of death among them. The pathogenesis of this aggressive neoplasm has been largely elusive until recently, when comprehensive genome-wide analyses of uterine serous carcinoma have been performed. Among amplified cancer-related genes, CCNE1, encoding for cyclin E1, is frequently amplified in uterine serous carcinoma. In the current study we applied fluorescence in situ hybridization (FISH) to determine CCNE1 copy number in uterine serous carcinoma and concurrent endometrial intraepithelial carcinoma, the noninvasive component of uterine serous carcinoma, and the results were correlated with clinicopathological and molecular features. We found that 20 (45%) of 44 uterine serous carcinomas and 11 (41%) of 27 endometrial intraepithelial carcinomas showed CCNE1 amplification. Overall, we found high concordance in CCNE1 copy number in concurrent uterine serous carcinoma and endometrial intraepithelial carcinoma pairs (P-value=0.0003). No correlation was observed between CCNE1 copy number and clinicopathological features, as well as common mutations previously reported in uterine serous carcinoma. In summary, we confirm that amplification of CCNE1 is a frequent molecular genetic change in uterine serous carcinoma. Moreover, the identification of CCNE1 amplification in many endometrial intraepithelial carcinomas suggests that this genetic event occurs early during tumor progression.

AB - Uterine serous carcinoma accounts for only 10% of all uterine epithelial cancers, but is the leading cause of death among them. The pathogenesis of this aggressive neoplasm has been largely elusive until recently, when comprehensive genome-wide analyses of uterine serous carcinoma have been performed. Among amplified cancer-related genes, CCNE1, encoding for cyclin E1, is frequently amplified in uterine serous carcinoma. In the current study we applied fluorescence in situ hybridization (FISH) to determine CCNE1 copy number in uterine serous carcinoma and concurrent endometrial intraepithelial carcinoma, the noninvasive component of uterine serous carcinoma, and the results were correlated with clinicopathological and molecular features. We found that 20 (45%) of 44 uterine serous carcinomas and 11 (41%) of 27 endometrial intraepithelial carcinomas showed CCNE1 amplification. Overall, we found high concordance in CCNE1 copy number in concurrent uterine serous carcinoma and endometrial intraepithelial carcinoma pairs (P-value=0.0003). No correlation was observed between CCNE1 copy number and clinicopathological features, as well as common mutations previously reported in uterine serous carcinoma. In summary, we confirm that amplification of CCNE1 is a frequent molecular genetic change in uterine serous carcinoma. Moreover, the identification of CCNE1 amplification in many endometrial intraepithelial carcinomas suggests that this genetic event occurs early during tumor progression.

KW - amplification

KW - CCNE1

KW - cyclin E1

KW - endometrial intraepithelial carcinoma

KW - FISH

KW - fluorescence in situ hybridization

KW - serous carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84903776015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903776015&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2013.209

DO - 10.1038/modpathol.2013.209

M3 - Article

VL - 27

SP - 1014

EP - 1019

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 7

ER -